Genetic markings could spot cancer before it develops

New research has found unique DNA markings on certain genes may 'predict' the risk of developing head and neck cancer

2013-10-01

(Press-News.org) Unique DNA markings on certain genes may "predict" the risk of developing head and neck cancer, according to new research led by Queen Mary University of London.

The findings, published today in the journal Cancer, raise the potential for the development of non-invasive tests which could pick up these tell-tale signs of early cancer initiation.

Head and neck cancers are cancers that develop anywhere in the head and neck, including mouth cancer and throat cancer. About 16,000 people in the UK are diagnosed with head and neck cancer every year*.

In this study scientists analysed clinical specimens of malignant tissue from 93 cancer patients from Norway and the UK. These were compared with either tissue donated by healthy individuals undergoing wisdom tooth extractions, or with non-cancerous tissue from the same patients.

They were trying to identify whether there were any epigenetic changes in the cancerous cells which were not seen in the healthy cells. Epigenetics is the study of changes in gene expression caused by mechanisms other than changes in the underlying DNA sequence.

Not all genes are active all the time and there are many ways that gene expression is controlled. DNA methylation marks act as 'switches', either turning genes on or off. Abnormal DNA methylation is known to precede cancer initiation.

Lead researcher Dr Muy Teck-Teh, from the Institute of Dentistry at Queen Mary, said: "In this study we have identified four genes which were either over or under-expressed in head and neck cancer. The expression of these genes was inversely correlated with particular DNA methylation marks, suggesting the genes are epigenetically modified in these cancers.

"These epigenetic markers could be clinically exploited as biomarkers for early pre-cancer screening of head and neck cancer. However, further work is needed, as we are purely at the discovery stage at the moment and have not used this as a diagnostic test as yet.

"The eventual aim would be to test asymptomatic patients and/or people with unknown mouth lesions. An advantage of epigenetic DNA markers is that it may be possible to measure them using non-invasive specimens. So it could enable the use of saliva, buccal scrapes or blood serum for early cancer screening, diagnosis and prognosis."

Consultant oral and maxillofacial surgeon Professor Iain Hutchison, co-author on the study, said he was excited by the possibility of diagnostic tests as a result of the research.

"All of us mouth cancer surgeons want to catch the cancer early when the chances of cure are high and the effects of surgery on the patient are minimal. A simple test using the patient's blood or saliva could mean many patients with pre-cancer changes in the mouth or throat will be treated early and the cancer will never progress."

The study was partly funded by the research charity Saving Faces – The Facial Surgery Research Foundation. Professor Hutchison founded the charity, which aims to reduce facial injuries and diseases through medical research.

###

*Figures from NHS Choices website -- http://www.nhs.uk/conditions/cancer-of-the-head-and-neck/Pages/Definition.aspx

About Queen Mary University of London

Queen Mary University of London is one of the UK's leading research-focused higher education institutions with some 17,840 undergraduate and postgraduate students.

A member of the Russell Group, it is amongst the largest of the colleges of the University of London. Queen Mary's 4,000staff deliver world class degree programmes and research across 21 academic departments and institutes, within three Faculties: Science and Engineering; Humanities and Social Sciences; and the School of Medicine and Dentistry.

Queen Mary is ranked 11th in the UK according to the Guardian analysis of the 2008 Research Assessment Exercise, and has been described as 'the biggest star among the research-intensive institutions' by the Times Higher Education.

The College has a strong international reputation, with around 20 per cent of students coming from over 100 countries. Queen Mary has an annual turnover of £300m, research income worth £90m, and generates employment and output worth £600m to the UK economy each year.

The College is unique amongst London's universities in being able to offer a completely integrated residential campus, with a 2,000-bed award-winning Student Village on its Mile End campus.

ELSE PRESS RELEASES FROM THIS DATE:

Total hospital cost of robotic or conventional open-chest mitral valve repair surgery is similar

2013-10-01

ROCHESTER, Minn. --The total hospital cost of mitral valve repair surgery -- from the time a patient is admitted to the hospital until release --is similar, whether performed through small port incisions using robotic equipment or via the conventional open-chest method, a Mayo Clinic study of 370 patients found. Importantly, robotic surgeries were just as safe as conventional open procedures, but patients who underwent robotic mitral valve repair recovered more rapidly and returned home earlier than patients who had open-chest surgery, the study found. The results of the ...

Despite menu changes, calorie and sodium levels in chain restaurant entrees remain the same overall

2013-10-01

(SACRAMENTO, Calif.) —Although a number of chain restaurants have announced healthy menu changes over the years, the overall calorie and sodium levels in main entrées offered by top U.S. chain restaurants assessed from 2010 to 2011 have remained the same, according to a study published today in the Journal of the Academy of Nutrition and Dietetics. The study, "Changes in the Energy and Sodium Content of Main Entrées in U.S. Chain Restaurants from 2010 to 2011," evaluated the nutritional content changes of more than 26,000 regular menu entrées in a year by 213 major U.S. ...

Study: New medical device extremely effective at preventing immunodeficiency virus

2013-09-30

It's often said that the HIV/AIDS epidemic has a woman's face. The proportion of women infected with HIV has been on the rise for a decade; in sub-Saharan Africa, women constitute 60 percent of people living with disease. While preventative drugs exist, they have often proven ineffective, especially in light of financial and cultural barriers in developing nations. A new intravaginal ring filled with an anti-retroviral drug could help. Developed with support from the National Institute of Allergy and Infectious Diseases by Northwestern University visiting associate professor ...

KAIST announced a novel technology to produce gasoline by a metabolically engineered microorganism

2013-09-30

Daejeon, Republic of Korea, September 29, 2013 -- For many decades, we have been relying on fossil resources to produce liquid fuels such as gasoline, diesel, and many industrial and consumer chemicals for daily use. However, increasing strains on natural resources as well as environmental issues including global warming have triggered a strong interest in developing sustainable ways to obtain fuels and chemicals. Gasoline, the petroleum-derived product that is most widely used as a fuel for transportation, is a mixture of hydrocarbons, additives, and blending agents. ...

Researchers uncover 48 new genetic variants associated with multiple sclerosis

2013-09-30

Scientists of the International Multiple Sclerosis Genetics Consortium (IMSGC) have identified an additional 48 genetic variants influencing the risk of developing multiple sclerosis. This work nearly doubles the number of known genetic risk factors and thereby provides additional key insights into the biology of this debilitating neurological condition. The genes implicated by the newly identified associations underline the central role played by the immune system in the development of multiple sclerosis and show substantial overlap with genes known to be involved in other ...

Promising results for new antibody drug in non-small cell lung cancer patients: Smokers respond well

2013-09-30

New results from a trial of an antibody that helps the immune system to recognise and attack cancer cells have shown particularly encouraging responses in patients who are smokers or former smokers. Presenting the most up-to-date data from 85 patients with non-small cell lung cancer in a large, phase I clinical trial of an experimental drug called MPDL3280A, Professor Jean-Charles Soria told the 2013 European Cancer Congress (ECC2013) [1] today (Sunday): "This is the first study to suggest a potential relationship between smoking history and response to inhibiting the ...

Identifying the disease-causing mechanisms in cancers with unknown primary site improves treatment

2013-09-30

Identifying the molecular profile of a tumour where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013) [1], will hear on Monday. In up to five percent of all cancers, the site of the primary tumour is unknown and the disease is not diagnosed until it is at an advanced stage, when the cancer has metastasised (spread to other parts of the body). Until recently, the choice of treatment has been based on efforts to find biomarkers that could indicate the site of origin, but now a team of researchers has succeeded in ...

Organized screening for prostate cancer does more harm than good

2013-09-30

Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from routine PSA screening, according to research to be presented on Monday by Professor Mathieu Boniol, at the 2013 European Cancer Congress (ECC2013) [1]. Prof Boniol, Research Director at the International Prevention Research Institute (iPRI) and Professor at the Strathclyde Institute for Global Public Health at iPRI, Lyon, France, will ...

Leukemia cells are addicted to a healthy gene

2013-09-30

What keeps leukemia cells alive almost forever, able to continue dividing endlessly and aggressively? New research at the Weizmann Institute suggests that, in around a quarter of all leukemias, the cancer cells rely on an internal "balance of terror" to keep going. When one version of a certain gene is mutated, it becomes a cancer-promoting gene – an oncogene. But the new findings show that the second, normal version of the gene, which functions alongside the mutation, is what keeps the cells both cancerous and alive, able to continue forging their destructive pathway in ...

Eilat's corals stand better chance of resilience than other sites

2013-09-30

Jerusalem, Sept. 29, 2013 – Israel's southern Red Sea resort of Eilat, one of whose prime attractions is its colorful and multi-shaped underwater coral reefs, may have a clear advantage in the future over rival coral-viewing sites around the world, scientists at the Hebrew University of Jerusalem and Bar-Ilan University have found. Coral reefs, earth's richest and most diverse ecosystem, are deteriorating rapidly. One of the most devastating causes for that deterioration is coral bleaching, which typically occurs when seawater temperatures exceed the local summer maximum ...

The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Con

Jeonbuk National University researchers explore the impact of different seasonings on the flavor perception of Doenjang soup

Two Keck Medicine of USC Hospitals named Leapfrog Top Teaching Hospitals

[Press-News.org] Genetic markings could spot cancer before it develops
New research has found unique DNA markings on certain genes may 'predict' the risk of developing head and neck cancer

Genetic markings could spot cancer before it develops

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: